Martingale Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,313
| Closed | -$252K | – | 842 |
|
|
2024
Q1 | $252K | Sell |
25,313
-400
| -2% | -$3.99K | 0.01% | 732 |
|
|
2023
Q4 | $254K | Buy |
25,713
+600
| +2% | +$5.92K | 0.01% | 724 |
|
|
2023
Q3 | $192K | Sell |
25,113
-89
| -0.4% | -$681 | ﹤0.01% | 752 |
|
|
2023
Q2 | $188K | Sell |
25,202
-198
| -0.8% | -$1.48K | ﹤0.01% | 771 |
|
|
2023
Q1 | $169K | Buy |
25,400
+200
| +0.8% | +$1.33K | ﹤0.01% | 791 |
|
|
2022
Q4 | $194K | Hold |
25,200
| – | – | ﹤0.01% | 794 |
|
|
2022
Q3 | $269K | Buy |
25,200
+14,100
| +127% | +$151K | 0.01% | 728 |
|
|
2022
Q2 | $91K | Buy |
+11,100
| New | +$91K | ﹤0.01% | 830 |
|